EUCTR2019-003073-25-PL
Active, not recruiting
Phase 1
A multi-centre clinical trial evaluating safety and patients' ability to independently use the medicinal product indicated in the treatment of erectile dysfunction
Overview
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Adamed Pharma S.A.
- Enrollment
- 400
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- Male
Inclusion Criteria
- •1\. Sex: male.
- •2\. Patients aged 18 years and older.
- •3\. Patients able to understand and follow the study procedures.
- •4\. Patients who report erectile dysfunction during the clinical examination.
- •5\. Patients who are willing to use pharmacological treatment of erectile dysfunction.
- •6\. Patients who have had at least one visit to a cardiologist over the past two years and remain under his care due to the diagnosed disorders (additional criterion only for inclusion into the group of patients with cardiac disorders – at least 80 patients in the study)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 300
Exclusion Criteria
- •1\. Lack of reading and writing skills or comprehension in Polish.
- •2\. Severe physical or mental concomitant disease that might hamper the realization of the trial according to the protocol.
- •3\. Legal issues (eg. incapacitation) or others that make the patient unable to fully understand the purpose of the study, description of its course and possible consequences.
- •4\. Unreliability or lack of cooperation.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment.CTIS2024-515481-13-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud20
Not yet recruiting
Phase 1/2
Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment.2024-515481-13-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud20
Completed
Not Applicable
ses of herbal combination by taking it in hot water in covid 19 positive patients.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J108- Influenza due to other identifiedinfluenza virus with other manifestationsCTRI/2020/07/026631Kumarans fertility centre30
Completed
Not Applicable
Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib TherapyChronic Phase Chronic Myelogenous LeukemiaJPRN-UMIN000007221Juntendo University School of Medicine40
Completed
Not Applicable
aser Intervention in Early Age-Related Macular Degeneration (LEAD) StudyAge related Macular DegenerationEye - Diseases / disorders of the eyeACTRN12612000704897Centre for Eye Research Australia360